These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 35217094)

  • 1. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series.
    Martins M; Bridoux F; Goujon JM; Meuleman MS; Ribes D; Rondeau E; Guerry MJ; Delmas Y; Levy B; Ducloux D; Kandel-Aznar C; Le Fur A; Garrouste C; Provot F; Gibier JB; Thervet E; Bruneval P; Rabant M; Karras A; Dragon Durey MA; Fremeaux-Bacchi V; Chauvet S
    Am J Kidney Dis; 2022 Sep; 80(3):341-352. PubMed ID: 35217094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features.
    Chabannes M; Rabant M; El Sissy C; Dragon-Durey MA; Vieira Martins P; Meuleman MS; Karras A; Buob D; Bridoux F; Daugas E; Audard V; Caillard S; Olagne J; Kandel C; Ferlicot S; Philipponnet C; Crepin T; Thervet E; Ducloux D; Frémeaux-Bacchi V; Chauvet S
    Am J Kidney Dis; 2023 Sep; 82(3):279-289. PubMed ID: 37061020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
    Che M; Moran SM; Smith RJ; Ren KYM; Smith GN; Shamseddin MK; Avila-Casado C; Garland JS
    Kidney Int; 2024 May; 105(5):960-970. PubMed ID: 38408703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
    Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies.
    Maisons V; Duval A; Mesnard L; Frimat M; Fakhouri F; Grangé S; Servais A; Cartery C; Fauchier L; Coppo P; Titeca-Beauport D; Fage N; Delmas Y; Quérard AH; Seret G; Bobot M; Le Quintrec M; Ville S; von Tokarski F; Chauvet S; Wynckel A; Martins M; Schurder J; Barbet C; Sautenet B; Gatault P; Caillard S; Vuiblet V; Halimi JM;
    Kidney Int; 2024 May; 105(5):1100-1112. PubMed ID: 38431217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic microangiopathy associated with monoclonal gammopathy.
    Ravindran A; Go RS; Fervenza FC; Sethi S
    Kidney Int; 2017 Mar; 91(3):691-698. PubMed ID: 27998645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.
    Menne J; Delmas Y; Fakhouri F; Licht C; Lommelé Å; Minetti EE; Provôt F; Rondeau E; Sheerin NS; Wang J; Weekers LE; Greenbaum LA
    BMC Nephrol; 2019 Apr; 20(1):125. PubMed ID: 30971227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.
    Le Clech A; Simon-Tillaux N; Provôt F; Delmas Y; Vieira-Martins P; Limou S; Halimi JM; Le Quintrec M; Lebourg L; Grangé S; Karras A; Ribes D; Jourde-Chiche N; Rondeau E; Frémeaux-Bacchi V; Fakhouri F
    Kidney Int; 2019 Jun; 95(6):1443-1452. PubMed ID: 30982675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S
    Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
    Rigothier C; Delmas Y; Roumenina LT; Contin-Bordes C; Lepreux S; Bridoux F; Goujon JM; Bachelet T; Touchard G; Frémeaux-Bacchi V; Combe C
    Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Kato H; Miyakawa Y; Hidaka Y; Inoue N; Ito S; Kagami S; Kaname S; Matsumoto M; Mizuno M; Matsuda T; Shimono A; Maruyama S; Fujimura Y; Nangaku M; Okada H
    Clin Exp Nephrol; 2019 Jan; 23(1):65-75. PubMed ID: 29959568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
    Huerta A; Arjona E; Portoles J; Lopez-Sanchez P; Rabasco C; Espinosa M; Cavero T; Blasco M; Cao M; Manrique J; Cabello-Chavez V; Suñer M; Heras M; Fulladosa X; Belmar L; Sempere A; Peralta C; Castillo L; Arnau A; Praga M; Rodriguez de Cordoba S
    Kidney Int; 2018 Feb; 93(2):450-459. PubMed ID: 28911789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies.
    Werion A; Storms P; Zizi Y; Beguin C; Bernards J; Cambier JF; Dahan K; Dierickx D; Godefroid N; Hilbert P; Lambert C; Levtchenko E; Meyskens T; Poiré X; van den Heuvel L; Claes KJ; Morelle J;
    Clin J Am Soc Nephrol; 2023 Jul; 18(7):881-891. PubMed ID: 37094330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
    Kistler AD
    Praxis (Bern 1994); 2016 Mar; 105(7):389-96. PubMed ID: 27005733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics.
    Fakhouri F; Frémeaux-Bacchi V
    Nat Rev Nephrol; 2021 Aug; 17(8):543-553. PubMed ID: 33953366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study.
    Laber DA; Patel PC; Logothetis CN; Patel AK; Jaglal M; Haider M; Visweshwar N; Rajasekaran-Rathnakumar G; Eatrides J
    Eur J Haematol; 2024 Mar; 112(3):450-457. PubMed ID: 37984551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleroderma Renal Crisis Associated With Microangiopathic Hemolytic Anemia in a Patient With Seronegative Scleroderma and Monoclonal Gammopathy.
    Riley M; Der Mesropian P; Maheshwari A; Arslan ME; Visrodia P; Salman L; Peredo-Wende R; Foulke L; Hongalgi K
    J Investig Med High Impact Case Rep; 2022; 10():23247096221074591. PubMed ID: 35152792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
    Asif A; Nayer A; Haas CS
    J Nephrol; 2017 Jun; 30(3):347-362. PubMed ID: 27848226
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.